Death without Previous Hospital Readmission in Patients with Heart Failure with Reduced Ejection Fraction—A New Endpoint from Old Clinical Trials

Background: Most of the drugs approved and registered for use in heart failure (HF) therapy were examined in randomized clinical trials (RCTs) with the primary composite endpoint of death or hospital readmission. This study aimed to analyze the rates of the newly calculated event: death without prio...

Descripción completa

Detalles Bibliográficos
Autores principales: Niedziela, Jacek T., Gąsior, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571697/
https://www.ncbi.nlm.nih.gov/pubmed/36233386
http://dx.doi.org/10.3390/jcm11195518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571697/
https://www.ncbi.nlm.nih.gov/pubmed/36233386
http://dx.doi.org/10.3390/jcm11195518

Ejemplares similares